Navigation Links
Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
Date:3/6/2008

Presented at Miami Breast Cancer Conference, study demonstrates BSGI is

both patient and cost effective.

NEWPORT NEWS, Va., March 6 /PRNewswire/ -- A recent study performed by Dr. Margaret Bertrand, Director of Breast Imaging at Solis Bertrand Breast Center in Greensboro, North Carolina demonstrated the significant value of Breast-Specific Gamma Imaging (BSGI) as an adjunctive procedure in breast diagnostics; specifically demonstrating BSGI to be a useful and cost effective procedure in the breast diagnostic work up. The study results were recently presented at the Miami Breast Cancer Conference.

Breast-Specific Gamma Imaging is a molecular breast imaging technique used for the early detection of breast cancer and in the differentiation of malignant and benign tumors. It relies on advanced gamma imaging technology and mammographic positioning to optimize results. For this study BSGI was conducted with a commercially available high-resolution gamma camera, the Dilon 6800.

Dr. Bertrand's study evaluated the clinical impact of BSGI as an adjunctive imaging modality in a comparative analysis with other imaging methods; using tissue biopsy as the gold standard. The facility conducted diagnostic workup, including BSGI, on 98 lesions consisting of 69 malignancies.

Because imaging was prescribed as necessary, not all modalities were employed for each case. Since all patients had both mammography and BSGI, these were established as the constants with US and MRI as variables. Seventy-five percent (64/75) of the lesions detected when BSGI was compared to MRI had concordant BSGI and MRI findings with 11 discrepancies. In 74 of the 75 lesions BSGI was conducted pre-biopsy, while MRI was conducted post-biopsy, therefore it is not certain if the MRI findings were positive due to biopsy or disease.

In addition, BSGI was False Negative (FN) in 3 patients and False Positive (FP) in 2, while MRI was FN for 1 patient and F
'/>"/>

SOURCE Dilon Technologies LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Finds Starion Instruments Tissue Welding Technology Safe and Effective in Parotidectomy Procedures
2. Thomson Healthcare Cancer Profiler Used in Study
3. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
4. Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)
5. CMC, Moffitt Partner to Study Cancer
6. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
7. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
8. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
9. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
10. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
11. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , RANCHO CORDOVA, Calif., Nov. 25 /PRNe...diary of American Pacific Corporation (Nasdaq: AP...ental Responsibility and Sustainability Award at t...d by the California Manufacturers and Technology A...sociation (IEA) and the Chemical Industry Council ...
(Date:11/25/2009)..., , HARBIN, China, Nov. 25 /PRNe...nc. ("China Sky One Medical" or "the Company") (Na...utical company developing and producing,over-the-c...RC"), today,announced that the Company recently pa...l of Pharmaceutical and Biological Products ("ICPB...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ ...search report is available in its catalogue: ,,...tive ,, http://www.reportlinker.com/p0164330...ve.html ,, Rising incidence of breast cancer i...a principal factor influencing growth in the mammo...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 1Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 2Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 3Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 4Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 13586 1Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 13586 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 1BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 3
...howed Campath May Lead to Overall Survival in Pati...NCISCO, Dec. 9 Bayer HealthCare Pharmaceuticals I...wing that treatment with Campath(R) (alemtuzumab) ...eukemia (CLL) patients who have poor prognostic in...h Annual Meeting of the American Society of Hemato...
...ANCISCO, Dec. 8 Millennium: The Takeda Oncology C...ended follow up of patients from the large, intern... survival improvement for patients with previously...an and prednisone (VcMP). The VELCADE combination ...b-groups, including those with poor prognostic cha...
Other Medicine Technology:Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 2Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 4Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 5Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 6Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 7Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 8Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 9Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 10Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
(Date:11/28/2009)... recognize signs of depression , , SATUR... the holiday season can trigger melancholy as they... issues or worry about money problems, according t...ercome the seasonal blues, the AGS Foundation for ...et out and socialize or invite family and friends ...
(Date:11/27/2009)...swire-FirstCall/ -- The Gymboree Corporation (Nasd... will present at the NASDAQ OMX 23rd Investor Prog...ondon, England, on Wednesday, December 2, 2009, at...st of The Gymboree Corporation,s presentation over...click on "Our Company" at the bottom of the page, ...
(Date:11/27/2009)...hicles may reduce future disease burden, researche...ws) -- Encouraging city dwellers to walk and bicyc...public health benefits than increased used of low-..., The study compared the projected health effects...rios for London, England, and Delhi, India: busin...
(Date:11/27/2009)...ufacturers who use medical load cells at the heart...by bringing in technology partner Flintec early in...ive medical manufacturers are calling in Flintec l...jects, ensuring that progress will not be constrai...tdated technology. , (PRW...
(Date:11/26/2009)...molybdate (TM) has been shown in studies to be eff...se caused by an overload of copper, and certain me... however, is known about how the drug works at the...ern University researchers now has provided an inv...M bound to copper-loaded metallochaperones. The dr...
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
... in revenues through early December , , OWING... ), a leading provider of easy-to-use, clinically ...day announced the company will exceed its previous...on. The Company now expects revenues in excess of ...
... Centers for Faith-Based and Community Initiatives...(USAID) and the Department of Homeland Security (D...ter collaboration in disaster response. The Seni...gether faith-based and community organizations (FB...
...STERIS Isomedix Services for a,one day seminar of...ccess in,medical device sterilization ( http://ww...ng held in San Jose, California on March 11, 2009,...addition to the TechTeam experts from STERIS Isome...
...ealth Blogging on Fire with ,Celebrity Psychings, ...and rock & roll was only the beginning. Today...ed the addition of "Celebrity Psychings," a new bl...essional blogger Alicia Sparks tackles issues head...
...th of stay either, study finds , , TUESDAY...tritional support for intensive care unit (ICU) pa...CU or their risk of death, according to a study by... admission) was important for critically ill patie...
...abetes increases cancer death risk , , TUE...lentil soup and pasta seems to be the way to go if...t a diet of "low-glycemic foods" -- such as beans...-- when it comes to lowering blood sugar and other...
Other Medicine News:Health News:Medifast to Exceed Revenue Guidance for 2008 2Health News:Medifast to Exceed Revenue Guidance for 2008 3Health News:Medifast to Exceed Revenue Guidance for 2008 4Health News:USAID and DHS Host Summit on Partnering with Faith-Based and Community Organizations for Disaster Response 2Health News:STERIS Isomedix Services Offers Medical Device Sterilization Seminar 2Health News:Celebrity Mental Health Musings Take Center Stage as Psych Central Adds New Blog 2Health News:Celebrity Mental Health Musings Take Center Stage as Psych Central Adds New Blog 3Health News:ICU Nutritional Program Failed to Boost Outcomes 2Health News:'Mediterranean'-Style Diet Best for Blood Sugar Control 2Health News:'Mediterranean'-Style Diet Best for Blood Sugar Control 3
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: